| Application no. and date | 22204250.9 (espacenet) (Federated) (European Patent Register), 20160701 | | Patent/reg. no. and date | DK/EP 4212536, 20250219 | | Publication date | 20230719 | | Priority no. and date | US 201562188029 P, 20150702 | | EP pub. no. and date |
EP 4212536 20230719 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | | | Inventor | BRAUN, Marie-Gabrielle,
South San Francisco, 94080, US,
ELLIOTT, Richard,
Harlow Essex, CM19 5TR, GB,
HANAN, Emily,
South San Francisco, 94080, US,
HEALD, Robert Andrew,
Herts, CM21 9LW, GB,
MACLEOD, Calum,
Harlow Essex, CM19 5TR, GB,
STABEN, Steven T.,
South San Francisco, 94080, US | | Representative | | | Opponent | | | IPC Class | A61K 31/553 (2006.01) , A61P 35/00 (2006.01) , C07D 498/04 (2006.01) | | Title | BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
